In the case of MEF2C, the set of its predicted target TF, includes archetypical myeloma PC dependencies, i.e., IRF4, PRDM1, thus in part explaining the high degree of myeloma cell dependency on MEF2C. This evidence concerns the gene MEF2C and plasma cell myeloma.